Related Experiment Video
Updated: Jul 10, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
SUMO4 and its role in type 1 diabetes pathogenesis
1Center for Biotechnology and Genomic Medicine, Department of Pathology, Medical College of Georgia, Augusta, GA 30912, USA. cwang@mcg.edu
Diabetes/Metabolism Research and Reviews
|November 9, 2007
Summary
The small ubiquitin-like modifier 4 (SUMO4) gene is linked to type 1 diabetes (T1D) susceptibility, particularly in Asian populations. Further research is needed to understand its role and explain differing results in Caucasian populations.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- Type 1 diabetes (T1D) susceptibility involves complex gene-environment interactions.
- Over 20 T1D susceptibility regions are known, but identifying specific genes remains challenging.
- The small ubiquitin-like modifier 4 (SUMO4) gene was identified in the IDDM5 region on chromosome 6q25.
Purpose of the Study:
- To review genetic evidence supporting SUMO4 as a T1D susceptibility gene.
- To discuss discrepancies in SUMO4 association studies across different ethnicities.
- To explore the pathogenic mechanisms of SUMO4 in T1D.
Main Methods:
- Review of existing genetic association studies.
- Analysis of functional data related to SUMO4.
- Comparative analysis of SUMO4's role in diverse populations.
Main Results:
- Consistent evidence supports SUMO4 as a T1D susceptibility gene in Asian populations.
- Controversial findings exist regarding SUMO4's association in Caucasian populations.
- SUMO4's role in T1D pathogenesis is under investigation.
Conclusions:
- SUMO4 is a significant candidate gene for T1D susceptibility, especially in Asians.
- Ethnic variations in SUMO4 association warrant further investigation.
- Understanding SUMO4's functional mechanisms is crucial for T1D research.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...